News

On August 27, 2025, Exosens Group officially announced that it has signed an agreement to acquire Phasics, initiating the acquisition process.  For more than two decades, Phasics has been at the forefront of high-resolution wavefront sensing, delivering precision solutions for laser systems, advanced imaging, and scientific research.

With access to Exosens’ complementary resources and international infrastructure, Phasics aims to gradually extend its international presence and reinforce its technological development efforts.

The proposed acquisition reflects a shared vision between the two companies in terms of technology, market strategy, and long-term objectives. Following completion, Phasics is expected to continue operating under its existing structure, with sustained focus on serving its customers worldwide.

We remain fully committed to delivering reliable products and services, and to supporting our research and industrial partners with the same rigor and excellence that have long defined our work.

As Marie-Begona Lebrun, CEO of Phasics, noted:

“We are very pleased with the prospect of joining the Exosens group. Exosens’ support should provide us with capabilities to scale up and to extend our geographical global reach while reinforcing our global offer to our customers. It represents a very exciting opportunity for the company”

Exosens is a French high-tech company specializing in advanced amplification, detection, and imaging technologies. Formerly known as the Photonis Group, it brings more than 85 years of expertise in R&D and manufacturing. Its technologies span the full spectrum from ultraviolet to long-wave infrared and are widely used in defense, nuclear monitoring, industrial inspection, and life sciences.

Through a strategy of targeted acquisitions and integration, Exosens has been progressively building a multi-sensor imaging platform. Its subsidiaries include image intensifiers tubes, particle detectioncooled and uncooled camera from UV to LWIR, , hyperspectral imaging. The group is headquartered in Bordeaux, with R&D and manufacturing centers across Europe and North America, and regional sales and support hubs in Asia and the Middle East. Exosens is publicly listed on Euronext Paris under the ticker EXENS.

The launch of this acquisition process reflects the shared values of both companies in technological innovation, international growth, and customer-centric development.

We sincerely thank our clients, distributors, partners, and team members for their continued trust and support. Together with Exosens, we look forward to advancing this integration and exploring new, forward-looking opportunities for growth.

— The Phasics Team